| 引用本文: | 王璐,姚立,金娅玮,金超英,董宇,寿旦,王一奇.桑黄多糖对人TLR4信号通路的激活作用研究[J].中国现代应用药学,2019,36(10):1178-1182. |
| WANG Lu,YAO Li,JIN Yawei,JIN Chaoying,DONG Yu,SHOU Dan,WANG Yiqi.Activation Effect of Human TLR4 Signaling Pathway by Polysaccharide from Phellinus Igniarius[J].Chin J Mod Appl Pharm(中国现代应用药学),2019,36(10):1178-1182. |
|
| 摘要: |
| 目的 观察桑黄多糖（polysaccharide from Phellinus igniarius，PPI）对人Toll-样受体4（Toll like receptor 4，TLR4）通路的激活作用及作用特点。方法 采用转染了人TLR4基因、分泌型胚胎碱性磷酸酶报告基因的HEK-BlueTM hTLR4细胞模型，快速评价PPI对TLR4通路的激活作用，并用PMA诱导的THP-1细胞模型观察药物对TLR4通路作用的特点；MTT法检测细胞活性；ELISA法检测细胞因子分泌量；Real time PCR检测细胞mRNA表达水平。结果 PPI作用24 h不影响细胞活性，但能剂量依赖性地增加HEK-BlueTM hTLR4细胞分泌型胚胎碱性磷酸酶的表达，并使THP-1细胞TLR4通路相关细胞因子TNF-α，IP-10分泌量增加。TLR4受体阻断剂TAK-242能显著降低PPI诱导的细胞因子分泌量（P<0.01）。Real-time PCR结果显示PPI既可以增加MyD88通路TNF-α、IL-6、IL-12、IL-1β、COX-2等细胞因子的mRNA表达，又可以增加TRIF通路IP-10、IFN-β等细胞因子的mRNA表达。结论 PPI对人TLR4受体具有直接激活作用，能同时激活TLR4下游MyD88和TRIF 2条分支，对TLR4分支通路的激活没有选择性。 |
| 关键词: 桑黄 多糖 TLR4 MyD88 TRIF |
| DOI：10.13748/j.cnki.issn1007-7693.2019.10.002 |
| 分类号:R285.5 |
| 基金项目:国家自然科学基金项目（81603363） |
|
| Activation Effect of Human TLR4 Signaling Pathway by Polysaccharide from Phellinus Igniarius |
|
WANG Lu1, YAO Li1, JIN Yawei1, JIN Chaoying1, DONG Yu2, SHOU Dan2, WANG Yiqi1
|
|
1.College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China;2.Zhejiang Academy of Traditional Chinese Medicine, Hangzhou 310007, China
|
| Abstract: |
| OBJECTIVE To observe the effect of polysaccharide from Phellinus igniarius (PPI) on human Toll like receptor 4 (TLR4) pathway.METHODS The activation of TLR4 pathway was evaluated rapidly by using HEK-BlueTM hTLR4 cells transfected with human TLR4 gene and secreted embryonic alkaline phosphatase reporter gene, and the PMA stimulated- THP-1 cells were used to observe the effects of drugs on the TLR4 pathway. The cell viability was detected by MTT assay. The cytokine secretion was evaluated by ELISA. mRNA expression level of the cells was analysed by Real-time PCR. RESULTS The treatment of PPI for 24 h did not affect cell viability but dose-dependently increased the expression of secreted embryonic alkaline phosphatase in HEK-BlueTM hTLR4 cells. In addition, the treatment of PPI leaded to increased secretion of TLR4 pathway-associated cytokines such as TNF-α and IP-10 in THP-1 cells. The TLR4 receptor blocker TAK-242 significantly reduced PPI-induced cytokine secretion (P<0.01). The results of Real-time PCR showed that PPI not only increased the mRNA expression of cytokines such as TNF-α, IL-6, IL-12, IL-1β and COX-2 in MyD88 pathway, but also increased the mRNA expression of cytokines such as IP-10 and IFN-β in TRIF pathway. CONCLUSION PPI is an agonist of the human TLR4, it can activate both MyD88 and TRIF branches on the downstream of TLR4 and show no selective activation of the two TLR4 branching pathways. |
| Key words: Phellinus igniarius polysaccharide TLR4 MyD88 TRIF |
